drugset / Trial / NCT00251225
A Study of Imatinib and Docetaxel in Prostate Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the effectiveness of two drugs, docetaxel and Gleevec®(also called imatinib), in prostate cancer that no longer responds to hormone therapy. The investigators are interested in finding out if the combination of these two drugs is more effective than docetaxel alone in the treatment of prostate cancer.
Timeline
- Start
- 2005-08
- Primary completion
- 2009-03
- Completion
- 2014-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Docetaxel | Small molecule | 60 mg/m2 | Intravenous |
| Subject | Imatinib | Small molecule | 400 mg | Oral |